These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9848574)

  • 1. Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units.
    Siu LL; Von Hoff DD; Rephaeli A; Izbicka E; Cerna C; Gomez L; Rowinsky EK; Eckhardt SG
    Invest New Drugs; 1998; 16(2):113-9. PubMed ID: 9848574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units.
    Hidalgo M; Izbicka E; Eckhardt SG; MacDonald JR; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD
    Anticancer Drugs; 1999 Oct; 10(9):837-44. PubMed ID: 10587294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the morpholino anthracycline 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin (MX2) against human tumor colony-forming units in vitro.
    Ebrahim el-Zayat AA; Izquierdo MA; Clark GM; Von Hoff DD
    Invest New Drugs; 1995; 13(2):125-131. PubMed ID: 8617574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of temozolomide against human tumor colony-forming units.
    Raymond E; Izbicka E; Soda H; Gerson SL; Dugan M; Von Hoff DD
    Clin Cancer Res; 1997 Oct; 3(10):1769-74. PubMed ID: 9815562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of DMP 840, a new bis-naphthalimide, on primary human tumor colony-forming units.
    Cobb PW; Degen DR; Clark GM; Chen SF; Kuhn JG; Gross JL; Kirshenbaum MR; Sun JH; Burris HA; Von Hoff DD
    J Natl Cancer Inst; 1994 Oct; 86(19):1462-5. PubMed ID: 8089865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units.
    Petit T; Izbicka E; Lawrence RA; Bishop WR; Weitman S; Von Hoff DD
    Ann Oncol; 1999 Apr; 10(4):449-53. PubMed ID: 10370788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the comparative effects of 2-chlorodeoxyadenosine on tumor colony forming units in vitro.
    Depenbrock H; Wenger M; Peter R; Fellbaum C; Block T; Rastetter J; Hanauske AR
    Invest New Drugs; 1995; 13(2):117-23. PubMed ID: 8617573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of oxaliplatin against human tumor colony-forming units.
    Raymond E; Lawrence R; Izbicka E; Faivre S; Von Hoff DD
    Clin Cancer Res; 1998 Apr; 4(4):1021-9. PubMed ID: 9563898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients.
    Izbicka E; Lawrence R; Raymond E; Eckhardt G; Faircloth G; Jimeno J; Clark G; Von Hoff DD
    Ann Oncol; 1998 Sep; 9(9):981-7. PubMed ID: 9818072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitro.
    Eckardt JR; Burris HA; Kuhn JG; Bissery MC; Klink-Alakl M; Clark GM; Von Hoff DD
    J Natl Cancer Inst; 1994 Jan; 86(1):30-3. PubMed ID: 8271279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro.
    Burris HA; Hanauske AR; Johnson RK; Marshall MH; Kuhn JG; Hilsenbeck SG; Von Hoff DD
    J Natl Cancer Inst; 1992 Dec; 84(23):1816-20. PubMed ID: 1331485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of TER286 against human tumor colony-forming units.
    Izbicka E; Lawrence R; Cerna C; Von Hoff DD; Sanderson PE
    Anticancer Drugs; 1997 Apr; 8(4):345-8. PubMed ID: 9180387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming units.
    Shimada Y; Rothenberg M; Hilsenbeck SG; Burris HA; Degen D; Von Hoff DD
    Anticancer Drugs; 1994 Apr; 5(2):202-6. PubMed ID: 8049503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of (-)-2'-deoxy-3'-oxacytidine (BCH-4556) against human tumor colony-forming units.
    Siu LL; Attardo G; Izbicka E; Lawrence R; Cerna C; Gomez L; Davidson K; Finkle C; Marsolais C; Rowinsky EK; Von Hoff DD
    Ann Oncol; 1998 Aug; 9(8):885-91. PubMed ID: 9789612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units.
    Marshall MV; Marshall MH; Degen DR; Roodman GD; Kuhn JG; Ross ME; Von Hoff DD
    Stem Cells; 1993 Jan; 11(1):62-9. PubMed ID: 8457783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells.
    Zimra Y; Wasserman L; Maron L; Shaklai M; Nudelman A; Rephaeli A
    J Cancer Res Clin Oncol; 1997; 123(3):152-60. PubMed ID: 9119880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of HMN-176 anticancer activity in human tumor specimens in vitro and the effects of HMN-176 on differential gene expression.
    Medina-Gundrum L; Cerna C; Gomez L; Izbicka E
    Invest New Drugs; 2005 Jan; 23(1):3-9. PubMed ID: 15528975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity of the cyclopropylpyrroloindole compounds adozelesin, bizelesin and carzelesin in a human tumor colony-forming assay.
    Hidalgo M; Izbicka E; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD
    Anticancer Drugs; 1999 Mar; 10(3):295-302. PubMed ID: 10327036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of NK 611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumours in vitro.
    Hanauske AR; Wüster KC; Lehmer A; Rotter M; Schneider P; Kaeser-Fröhlich A; Rastetter J; Depenbrock H
    Eur J Cancer; 1995 Sep; 31A(10):1677-81. PubMed ID: 7488424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units.
    Petit T; Izbicka E; Lawrence RA; Nalin C; Weitman SD; Von Hoff DD
    Anticancer Drugs; 1999 Mar; 10(3):309-15. PubMed ID: 10327038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.